Yüklüyor......
Use of mTOR inhibitors in the treatment of breast cancer: an evaluation of factors that influence patient outcomes
Many systemic treatment options are available for advanced breast cancer, including endocrine therapy, chemotherapy, anti-human epidermal growth factor receptor 2 (HER2) therapy, and other targeted agents. Recently, everolimus, a mammalian target of rapamycin (mTOR) inhibitor, combined with exemesta...
Kaydedildi:
| Asıl Yazarlar: | , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove Medical Press
2014
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4000187/ https://ncbi.nlm.nih.gov/pubmed/24833916 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BCTT.S38679 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|